Skip to main content

Nemes Rush Group LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1982273 NOVI, MI

Position in VKTX

as of Mar 31, 2026 · filed Apr 21, 2026
Position Value
$168,166
-$13,644 QoQ
Shares Held
5,168
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2026
CallValue
$9,762
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Nemes Rush Group LLC holds $2,865,515 across 18 Biotechnology names. VKTX ranks #2 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 VKTX
Viking Therapeutics, Inc.
This page
5,168 $168,166

All Filings in VKTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $168,166 5,168
2026-03-31 $9,762 300
2025-12-31 $10,554 300
2025-12-31 $181,810 5,168
2025-09-30 $7,884 300
2025-09-30 $134,028 5,100
2025-06-30 $135,150 5,100
2025-03-31 $123,165 5,100
2024-12-31 $201,200 5,000
2024-09-30 $316,550 5,000
2024-06-30 $265,050 5,000
2024-03-31 $410,000 5,000
2023-12-31 $93,050 5,000